Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biomarin Pharmaceut (BMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,506,161
  • Shares Outstanding, K 178,060
  • Annual Sales, $ 1,314 M
  • Annual Income, $ -117,040 K
  • 36-Month Beta 1.62
  • Price/Sales 12.95
  • Price/Cash Flow N/A
  • Price/Book 5.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.05
  • Number of Estimates 7
  • High Estimate 0.15
  • Low Estimate -0.17
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +83.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.25 +2.71%
on 11/15/18
101.72 -8.87%
on 11/08/18
-6.36 (-6.42%)
since 11/07/18
3-Month
90.00 +3.00%
on 10/26/18
106.74 -13.15%
on 10/17/18
-5.34 (-5.45%)
since 09/07/18
52-Week
75.81 +22.28%
on 04/06/18
106.74 -13.15%
on 10/17/18
+11.80 (+14.59%)
since 12/07/17

Most Recent Stories

More News
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 22.64 (-1.35%)
NGVC : 17.80 (-0.89%)
STC : 41.06 (-1.23%)
ATUS : 18.24 (-0.71%)
RBA : 33.28 (unch)
MHK : 120.44 (-2.09%)
NVCR : 33.63 (-2.24%)
CVSI : 5.0200 (+3.93%)
AC : 40.47 (-2.15%)
BSX : 35.48 (-3.51%)
HON : 138.71 (-2.01%)
POTND : 0.0200 (+32.45%)
PRTT : 1.3000 (unch)
TARSD : 0.2033 (-1.64%)
NKE : 73.34 (-2.91%)
ROIC : 17.94 (-0.94%)
DGX : 87.56 (-1.43%)
EIX : 58.51 (+1.69%)
GARLF : 0.0825 (+1.85%)
MRNA : 18.60 (-15.45%)
MSPC : 0.0002 (unch)
RYAAY : 75.58 (-6.04%)
BA : 323.22 (-2.62%)
BDC : 47.28 (-3.43%)
BC : 49.57 (-3.05%)
OXFD : 14.98 (-0.20%)
NDAQ : 87.36 (-2.81%)
TTOO : 4.17 (-4.36%)
DMAC : 3.10 (-22.50%)
CMCM : 6.57 (+5.29%)
ALGN : 210.28 (-4.13%)
ABM : 28.20 (-3.13%)
RTN : 165.11 (-1.83%)
IESC : 17.09 (+3.14%)
KIDS : 33.10 (+10.33%)
CYL.VN : 0.160 (+3.23%)
FLIR : 43.33 (-3.15%)
NETC.CN : 0.110 (unch)
SLCA : 13.06 (-4.53%)
BANX : 20.50 (+1.03%)
APOG : 34.44 (-1.82%)
RBBN : 5.09 (-2.30%)
SPLIF : 0.1562 (+16.74%)
SO : 46.98 (+0.99%)
SNWV : 0.2872 (+2.98%)
ACB : 5.75 (+8.90%)
CE : 91.26 (-3.59%)
QILFF : 0.2807 (-14.16%)
QILFD : 0.2331 (-29.98%)
MANH : 46.86 (-2.37%)
MKL : 1,048.23 (-8.69%)
HAL : 29.68 (-0.37%)
LZB : 27.06 (-2.28%)
INTC : 46.24 (-4.40%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,629.13 (-4.12%)
ACHC : 31.66 (-1.09%)
TX : 29.19 (-1.55%)
SRPT : 121.38 (-3.35%)
JOUT : 61.70 (-11.35%)
CCAN : 0.2353 (-1.96%)
OBMP : 0.0127 (+5.83%)
ELY : 16.60 (-1.66%)
DY : 56.18 (-6.72%)
HIPH : 0.0351 (+59.55%)
POTN : 0.1190 (-4.57%)
JWN : 49.36 (-2.62%)
SYF : 25.36 (+0.88%)
AQUA : 9.96 (+6.30%)
NWVCF : 0.9651 (+2.79%)
USYNF : 2.9783 (-2.53%)
EMR : 62.95 (-1.32%)
BXE : 0.70 (+2.19%)
HSY : 107.14 (-0.92%)
EW : 157.21 (-3.75%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 14.00 (-1.48%)
PSX : 90.35 (-2.43%)
MVIS : 0.57 (-13.64%)
PCI : 22.48 (-0.44%)
PCN : 15.17 (+0.66%)
AVT : 41.99 (-2.30%)
MGNX : 16.41 (-1.14%)
ICBK : 20.91 (+0.48%)
DLR : 115.72 (-1.01%)
RHI : 58.26 (-1.65%)
YVR : 2.99 (+3.10%)
PTY : 15.23 (+1.40%)
PDI : 30.15 (-0.10%)
TNXP : 2.94 (-6.67%)
GBT : 42.65 (-8.60%)
QI.VN : 0.290 (-27.50%)
TSRO : 73.95 (+0.23%)
RHP : 73.60 (-2.27%)
NKTR : 36.99 (-2.76%)
GOOG : 1,036.58 (-3.01%)
JBLU : 17.89 (-5.09%)
IGC : 2.49 (unch)
WBT : 12.98 (-1.29%)
WRY.VN : 0.020 (unch)
SAPIF : 30.5000 (+1.05%)
WSO : 152.05 (-1.46%)
LMT : 285.40 (-0.33%)
CMCSA : 37.41 (-1.24%)
HSDT : 9.16 (+3.27%)
GWRE : 85.01 (+0.29%)
CLGX : 38.16 (-2.05%)
FNSR : 22.49 (-2.26%)
SONS : 7.83 (+2.76%)
DEWM : 0.0013 (+18.18%)
SLG : 93.23 (-2.59%)
UPS : 105.32 (-2.52%)
PFN : 9.80 (+0.51%)
KMB : 113.50 (+0.52%)
ANZ.VN : 0.055 (unch)
TAOP : 1.12 (+1.82%)
NSU : 4.48 (+0.67%)
CBDS : 3.5700 (+5.12%)
CTXS : 107.37 (-1.78%)
PCOM : 10.51 (-0.57%)
HTHT : 30.11 (-4.26%)
MAN : 73.16 (-1.85%)
CNK : 38.93 (-1.77%)
AMAT : 33.64 (-3.03%)
FMCC : 1.2100 (+0.83%)
MRK : 76.72 (-2.11%)
ATOS : 1.32 (+1.54%)
WTCRF : 0.0187 (+16.87%)
MLRKF : 0.0822 (+9.16%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 53.65 (-0.32%)
COOL : 17.33 (-0.69%)
SAVE : 59.67 (-7.62%)
PCRX : 46.23 (-3.97%)
RNLSY : 13.0300 (-1.73%)
COL : 141.04 (-0.42%)
COR : 97.19 (-2.04%)
IDXG : 1.01 (-0.98%)
MCD : 182.96 (-1.34%)
ETST : 0.6578 (-17.77%)
QNIIF : 0.7975 (+6.33%)
PII : 88.46 (-2.57%)
AMRS : 4.34 (+4.08%)
SON : 56.09 (-0.55%)
MCK : 124.94 (-1.16%)
APHA : 5.23 (-5.60%)
MCO : 145.78 (-2.71%)
GSKY : 9.00 (+0.11%)
LH : 141.96 (-1.14%)
SAP.TO : 40.67 (-0.47%)
ODFL : 128.75 (-4.05%)
NEU : 404.83 (-0.83%)
ORTX : 15.09 (-5.57%)
BXE.TO : 0.94 (+2.17%)
GWPRF : 10.3900 (-0.57%)
PZN : 9.34 (-0.32%)
RBX.VN : 0.085 (unch)
RNG : 79.78 (-3.06%)
SPG : 188.42 (-1.14%)
TRVN : 0.63 (-3.54%)
AMC : 14.27 (-2.46%)
UTX : 119.45 (-1.65%)
AMD : 19.46 (-8.64%)
NDLS : 7.44 (-3.50%)
MPWR : 121.83 (-2.96%)
KGKG : 0.1000 (+6.27%)
FRO-UN.VN : 0.530 (unch)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 18.16 (-3.66%)
IQST : 1.3500 (-12.90%)
ASPS : 23.95 (+2.48%)
HMNY : 0.02 (unch)
ROP : 284.82 (-0.84%)
GOVB : 15.7500 (unch)
PKO : 25.23 (+0.92%)
MYGN : 31.51 (-1.93%)
CRL : 128.86 (-1.51%)
GLPH : 0.0315 (unch)
BXXRF : 0.0098 (+63.33%)
ADTN : 12.00 (-4.69%)
GRNH : 0.0180 (-6.74%)
NS : 24.60 (+1.07%)
LTS : 2.70 (-1.10%)
INT : 23.98 (-1.24%)
INPX : 3.62 (+1.40%)
GSPT : 0.1200 (unch)
MRO.VN : 0.100 (-4.76%)
COST : 224.86 (-3.58%)
EFX : 99.36 (-0.96%)
BMRN : 92.70 (-2.97%)
SPGI : 169.14 (-2.51%)
IGCC : 0.7464 (+6.63%)
PYPL : 82.77 (-3.55%)
LHSIF : 0.6596 (-6.45%)
TDY : 204.02 (-2.23%)
AZPN : 81.80 (-3.45%)
ENW.VN : 1.310 (+2.34%)
DMA.VN : 4.200 (-48.15%)
SNAP : 5.80 (-2.85%)
KSU : 98.22 (-2.13%)
MERC : 11.98 (-3.46%)
DVA : 58.96 (-4.63%)
UNI.VN : 4.250 (+3.91%)
MGI : 1.89 (-7.80%)
IGAP : 0.2000 (+17.65%)
FIT : 4.98 (-3.30%)
RAD : 1.01 (-1.94%)
LDSR : 0.0030 (+3.45%)
CYLYF : 0.1250 (-3.85%)
PMX : 11.62 (+0.52%)
ROBXF : 0.1851 (+262.94%)
BRO : 27.59 (-1.18%)
Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger

Shire's (SHPG) pending acquisition by Takeda Pharmaceuticals for $62 billion gets approval from shareholders of both the companies.

AGN : 152.42 (-1.99%)
BMRN : 92.70 (-2.97%)
INCY : 64.51 (-0.91%)
SHPG : 172.75 (-3.02%)
BioMarin Promotes Amy Wireman to Group Vice President, Human Resources

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the promotion of Amy Wireman to Group Vice President, Human Resources. Ms. Wireman's promotion to lead the Human Resources function globally...

BMRN : 92.70 (-2.97%)
BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's 13th Annual Biotech Conference on December 5 in New York City. To access the live webcast, please...

BMRN : 92.70 (-2.97%)
Watch for Biomarin Pharmac to Potentially Rebound After Falling 1.68% Yesterday

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $94.20 to a high of $97.11. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of...

BMRN : 92.70 (-2.97%)
Sarepta Stock More Than Doubles This Year So Far: Here's Why

Sarepta's (SRPT) key product, Exondys 51, continues to perform well. Its lead pipeline candidate, golodirsen, is also making good progress. The company is also developing gene therapies.

CRVS : 5.89 (-0.84%)
SRPT : 121.38 (-3.35%)
BMRN : 92.70 (-2.97%)
EXEL : 20.54 (-2.65%)
Biomarin Pharmac Set to Possibly Rebound After Yesterday's Selloff of 2.61%

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $91.08 to a high of $94.83. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of...

BMRN : 92.70 (-2.97%)
BioMarin to Participate in Two Investor Conferences in November

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in two investor conferences this November. To access the events that are accessible by live webcasts, please...

BMRN : 92.70 (-2.97%)
BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on November 7th in New York

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) updated the investment community on the Company's research and development portfolio, which is focused on innovative therapies to treat rare and ultra-rare diseases....

BMRN : 92.70 (-2.97%)
Market Votes for Clarity

Market Votes for Clarity

BABA : 153.06 (-1.78%)
WATT : 7.32 (-3.81%)
HK : 2.56 (-1.92%)
TNA : 53.14 (-6.25%)
BIDU : 179.56 (-0.63%)
UUUU : 3.41 (+4.92%)
SLB : 43.04 (+1.70%)
AEM : 39.92 (+4.09%)
HPR : 3.01 (-3.22%)
BMY : 53.08 (-0.32%)
EYE : 32.36 (-8.90%)
UWT : 14.63 (+4.13%)
SPXL : 38.89 (-7.10%)
BMRN : 92.70 (-2.97%)
TCEHY : 39.6800 (+0.69%)
GRUB : 76.80 (-5.66%)
TQQQ : 43.41 (-9.79%)
CGC : 31.40 (+3.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BMRN with:

Business Summary

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment...

See More

Key Turning Points

2nd Resistance Point 98.01
1st Resistance Point 95.35
Last Price 92.70
1st Support Level 90.81
2nd Support Level 88.93

See More

52-Week High 106.74
Fibonacci 61.8% 94.92
Last Price 92.70
Fibonacci 50% 91.27
Fibonacci 38.2% 87.63
52-Week Low 75.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar